Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
COVID-19 caused by SARS-CoV-2 has raised a health crisis worldwide. The high morbidity and mortality associated with COVID-19 and the lack of effective drugs or vaccines for SARS-CoV-2 emphasize the urgent need for standard treatment and prophylaxis of COVID-19. The receptor-binding domain (RBD) of...
Saved in:
Main Authors: | Xiao-Huan Liu (Author), Ting Cheng (Author), Bao-Yu Liu (Author), Jia Chi (Author), Ting Shu (Author), Tao Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
by: Deepa Raghu, et al.
Published: (2022) -
Development of a multi-epitope spike glycoprotein vaccine to combat SARS-CoV-2 using the bioinformatics approach
by: Aamir Shehzad, et al.
Published: (2022) -
Identifying plant-derived antiviral alkaloids as dual inhibitors of SARS-CoV-2 main protease and spike glycoprotein through computational screening
by: Ramsha Yamin, et al.
Published: (2024) -
Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models
by: Antimo Cutone, et al.
Published: (2022) -
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
by: Santosh Kumar Singh, et al.
Published: (2021)